Skip to main content
. 2015 Oct 7;10(10):e0140120. doi: 10.1371/journal.pone.0140120

Fig 2. Binding affinities of anti-CD20 IgG1 rituximab variants for shFcRIIIa (V), shFcRIIIa (F), shFcRIIIb, shFcRIIa, and shFcRI.

Fig 2

Binding affinities of the nonfucosylated antibodies (A, C, E, G, I) and fucosylated antibodies (B, D, F, H, J) for shFcRIIIa (V), shFcRIIIa (F), shFcRIIIb, shFcRIIa, and shFcRI were determined using Surface Plasmon Resonance(SPR) measurement. The mean K D value (n = 3) is indicated on the Y axis; bars ± standard deviations (SDs). Dashed lines indicate the K D value of the wild-type antibodies. *, the K D value of Y296P was more than 100 × 10−8 M. n.d., not detected.